MFN Partners Management LP 13D and 13G filings for Cyclerion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-12 3:36 pm Sale | 2024-12-31 | 13G | Cyclerion Therapeutics, Inc. CYCN | MFN Partners Management LP | 0 0.000% | -121,384 (Position Closed) | Filing |
| 2021-02-12 5:09 pm Purchase | 2020-12-31 | 13G | Cyclerion Therapeutics, Inc. CYCN | MFN Partners Management LP | 121,384 7.150% | 46,990 (+63.16%) | Filing |